A share price of HUTCHMED (China) Limited ADR [HCM] is currently trading at $18.56, up 13.66%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The HCM shares have gain 24.56% over the last week, with a monthly amount glided 31.44%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 28, February 2024, HUTCHMED Reports 2023 Full Year Results and Provides Business Updates. In a post published today on Yahoo Finance, Revenue grew 97% (102% CER) to US$838 million, with net income of US$101 million.
From an analyst’s perspective:
HUTCHMED (China) Limited ADR [NASDAQ: HCM] stock has seen the most recent analyst activity on November 24, 2023, when Deutsche Bank upgraded its rating to a Buy. Previously, Deutsche Bank downgraded its rating to Hold on May 04, 2022. On September 22, 2021, downgrade downgraded it’s rating to Neutral but maintained its price target of $46 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $52 on August 03, 2021. Deutsche Bank initiated its recommendation with a Buy and recommended $40 as its price target on October 02, 2020. In a note dated February 20, 2020, Goldman initiated an Buy rating.
HUTCHMED (China) Limited ADR experienced fluctuations in its stock price throughout the past year between $10.68 and $20.73. HUTCHMED (China) Limited ADR [NASDAQ: HCM] shares were valued at $18.56 at the most recent close of the market.
Analyzing the HCM fundamentals
Trailing Twelve Months sales for HUTCHMED (China) Limited ADR [NASDAQ:HCM] were 844.58M which represents 53.61% growth. Gross Profit Margin for this corporation currently stands at 0.16% with Operating Profit Margin at 0.01%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.11%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.12 and Total Capital is 0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 18.07 points at the first support level, and at 17.59 for the second support level. However, for the 1st resistance point, the stock is sitting at 19.22, and for the 2nd resistance point, it is at 19.89.
Ratios To Look Out For
To put it in perspective, the Current Ratio for HUTCHMED (China) Limited ADR [NASDAQ:HCM] is 2.72. In addition, the Quick Ratio stands at 2.60 and the Cash Ratio stands at 0.7. Considering the valuation of this stock, the price to sales ratio is 3.83, the price to book ratio is 4.43 and price to earnings (TTM) ratio is 32.30.
